Global Respiratory Care Devices Market to Reach USD 49.19 Billion by 2033

Introduction

According to Renub Research, the global respiratory care devices market was valued at USD 24.16 billion in 2024 and is projected to reach USD 49.19 billion by 2033, growing at a CAGR of 8.22% during the forecast period.

The market growth is primarily fueled by the rising prevalence of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea, as well as increasing demand for advanced medical devices like ventilators, oxygen concentrators, and CPAP machines.

Overview of Respiratory Care Devices

Respiratory care devices are essential medical tools designed to assist individuals who experience difficulty breathing due to underlying respiratory conditions. They are widely used for the diagnosis, management, and treatment of diseases such as asthma, COPD, pneumonia, sleep apnea, and respiratory distress syndrome.

Common Respiratory Care Devices

Ventilators: Provide mechanical breathing support for critically ill patients

Nebulizers: Deliver medication directly to the lungs as a fine mist

Oxygen Concentrators: Supply oxygen to individuals with low blood oxygen levels

CPAP (Continuous Positive Airway Pressure) Machines: Manage sleep apnea effectively

These devices are used across hospitals, clinics, and home care settings, enhancing patient outcomes, reducing breathing effort, and improving overall quality of life.

👉 Want to explore detailed market trends, segment insights, and forecasts? 🔗 Request Free Sample Report

Key Market Drivers

Rising Incidence of Respiratory Disorders

The global increase in respiratory diseases is a significant driver for the respiratory care devices market. Factors contributing to this growth include:

Air pollution and occupational hazards

Smoking and lifestyle-related health issues

Aging population with declining lung function

The World Health Organization (WHO) estimates that chronic respiratory diseases account for 4.1 million deaths annually, emphasizing the need for effective respiratory care solutions.

Technological Advancements

Recent innovations have transformed respiratory care devices into smarter and more portable systems, incorporating:

Wireless connectivity and remote monitoring

Artificial intelligence for precise data analysis

Smart inhalers and wearable oxygen devices

Example: In January 2024, IMVARIA Inc. received FDA approval for Fibresolve, an AI-based non-invasive lung fibrosis diagnostic solution, allowing integration into healthcare systems with CPT billing codes.

Increasing Awareness and Healthcare Spending

Governments, NGOs, and private organizations are promoting screening programs and respiratory health education

Expanding healthcare infrastructure and improved reimbursement policies increase accessibility to respiratory devices

Example: Royal Philips announced a new R&D center in Maharashtra, India in April 2024, focusing on sleep and respiratory care technologies

Regional Market Analysis

North America

The United States dominates the North American respiratory care devices market due to high prevalence of chronic respiratory diseases and strong healthcare infrastructure.

Adoption of portable oxygen concentrators, non-invasive ventilators, and smart monitoring devices is increasing

Example: React Health acquired Invacare’s respiratory line in February 2023, expanding its product portfolio

Europe

Germany is a key player in Europe, driven by an aging population, high COPD prevalence, and a strong medical device innovation ecosystem.

COPD patient base in Germany estimated at 2.7 million in 2019

Demand for oxygen therapy devices, high-flow nasal cannulas, and portable ventilators is increasing

Asia-Pacific

China leads the Asia-Pacific market due to rising air pollution, high smoking rates, and an aging population.

Government initiatives enhance healthcare access and adoption of advanced devices

Example: Canta Medical’s oxygen concentrators supplied to La Paz in November 2022 demonstrate reliability and global reach

Latin America

Brazil shows significant growth due to rising chronic respiratory diseases, urban pollution, and government initiatives to improve healthcare access.

Adoption of portable oxygen concentrators and non-invasive ventilators is increasing

Regulatory updates like ANVISA RDC 665/2022 standardize medical device practices

Middle East & Africa

Saudi Arabia: Market growth is supported by rising respiratory conditions and investments in healthcare infrastructure under Vision 2030.

South Africa: Dominates the African market due to high prevalence of respiratory diseases, urban pollution, and government collaborations with medical device companies

Technological Innovations and Key Company Developments

Medtronic

Launched Puritan Bennett 980 ventilator in 2020, offering advanced algorithms for personalized ventilation

Plans to merge patient tracking and respiratory businesses (February 2024)

Koninklijke Philips

Released Trilogy Evo ventilator (2021) for acute and chronic respiratory failure

Halted sales of some respiratory care products in the US due to regulatory consent decree (January 2024)

General Electric (GE) Healthcare

Launched Carescape R860 ventilator in 2020, offering personalized ventilation modes and advanced monitoring

Masimo Corporation

Acquired NantHealth’s Connected Care Business (January 2020) for integrated patient monitoring

ResMed Inc.

Released AirSense 11 AutoSet CPAP device in 2021 with AI-enabled automatic pressure adjustment

Introduced AirFit F30i full-face mask in 2020 for maximum comfort and mobility

Getinge AB

Launched Servo-C mechanical ventilator in January 2023 for ICU applications

Inogen Inc.

Released Rove 6 device in Europe (December 2022) with an 8-year expected service life

Rove 4 (US, 2023) received FDA market clearance

👉 For deeper analysis, detailed segment data, and company insights: 🔗 Request Customization Report

Market Segmentation

By Device Type

Therapeutic Devices

Monitoring Devices

Diagnostic Devices

Consumables & Accessories

By Products

Respiratory Consumables

Nebulizers

Oxygen Concentrators

Polysomnography Devices

Pulse Oximeters

Mechanical Ventilators

Spirometers

Others

By Application

COPD

Obstructive Sleep Apnea

Asthma

Respiratory Distress Syndrome

Cystic Fibrosis

Others

By End-User

Hospitals

Home Care

Ambulatory Care

By Region

North America: USA, Canada

Latin America: Mexico, Brazil

Europe: UK, Germany, France, Italy, Spain, Netherlands

Asia-Pacific: China, Japan, India, South Korea, Australia

Middle East & Africa: UAE, South Africa, Rest of the World

Competitive Landscape

Key Companies:

Medtronic Plc

Koninklijke Philips

General Electric Company

Masimo Corporation

ResMed Inc.

Becton Dickinson

Chart Industries Inc.

Getinge AB

Inogen Inc.

Companies are focusing on R&D, strategic acquisitions, and expansion of product portfolios to strengthen their presence in the global respiratory care devices market.

Future Outlook

The global respiratory care devices market is expected to witness substantial growth through 2033, driven by:

Increasing respiratory disorder prevalence

Rising adoption of advanced and AI-enabled respiratory devices

Expansion of home healthcare and remote monitoring

Enhanced awareness, government initiatives, and healthcare spending

Challenges such as regulatory hurdles and affordability exist, but technological innovations, strategic partnerships, and growing demand in emerging markets will continue to propel growth globally.

Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.